Showing Results for: “type 1 diabetes”

Multi-year public health campaign will raise awareness of the need for understanding and early detection of diabetes-related eye disease The American Diabetes Association (ADA) today announced Regeneron Pharmaceuticals, Inc., has joined VSP® Vision Care as a Visionary Partner to focus on an often overlooked but costly and devastating complication of diabetes: vision loss. This eye health initiative, “Focus on Diabetes,” will highlight the crucial role annual comprehensive eye exams play in the early detection, intervention and possible prevention of eye disease and vision loss caused by

Leading Diabetes Scientific Sessions Meeting Will Present Groundbreaking Data on Key Topics Including: Obesity, Technology, AI Health and the Latest in Diabetes Innovation From June 21–24, the American Diabetes Association® (ADA) will host the 84th Scientific Sessions in Orlando, FL. The ADA’s Scientific Sessions is the world’s largest diabetes meeting, convening more than 11,000 leading physicians, scientists, researchers and health care professionals from around the globe. The hybrid meeting will feature the latest scientific findings in diabetes, including more than 200 sessions and 2,000

Get the right care for you- learn as much as possible about the latest medical therapies and approaches, as well as healthy lifestyle choices.

Read more on new generation of insulin pens that are smarter, more affordable, and easier to use. Manage your insulin delivery with intuitive smartphone apps and helpful reminders.